Fostair Nexthaler

Fostair Nexthaler combines formoterol and beclometasone for respiratory conditions. This inhalation medication helps manage symptoms like wheezing and shortness of breath.

Fostair Nexthaler is primarily used for the maintenance treatment of asthma and chronic obstructive pulmonary disease (COPD). It contains formoterol, a long-acting beta-agonist, and beclometasone, a corticosteroid. These components work together to reduce inflammation and relax the airways, making it easier to breathe. Patients often use this medication to prevent symptoms such as wheezing, coughing, and shortness of breath.

Common effects of Fostair Nexthaler may include throat irritation, hoarseness, and a dry mouth. Some users might experience tremors, headaches, or an increased heart rate. These effects are generally mild and temporary, but persistent or severe symptoms should be discussed with a healthcare provider.

Fostair Nexthaler should be used as directed by a healthcare professional. It is important to follow the prescribed dosage and administration instructions. Patients should rinse their mouth after each use to reduce the risk of throat irritation and fungal infections. This medication should not be used to treat sudden breathing problems; a rescue inhaler should be used for acute symptoms.

Fostair Nexthaler may interact with other medications, including beta-blockers, diuretics, and certain antidepressants. It is important to inform your healthcare provider about all medications you are taking. Additionally, patients should avoid using other inhaled corticosteroids or long-acting beta-agonists unless directed by a healthcare professional.